Proton Pump Inhibitors in Pediatric Patients

                                                                                                Indicated Ages

Lansoprazole                                                                          Approved for children ages 1–17 y

Omeprazole                                                                            Approved for children ages 2–16 y

Esomeprazole magnesium                                                     Approved for children ages 1–17 y

Pantoprazole sodium                                                              Approved for children ages 12–17 y

Rabeprazole sodium                                                               Approved for children ages 12–17 y

Omeprazole/sodium bicarbonate                        

Safety and effectiveness in pediatric patients have not been established.

Indeed, even though most PPIs are not FDA-approved for infants, some pediatric physicians have had success with this treatment for this younger age group. With either approach, care must be taken when prescribing PPIs for infants.